These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 16332985)

  • 1. Differential gene expression as a potential classifier of 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole-sensitive and -insensitive cell lines.
    Wallqvist A; Connelly J; Sausville EA; Covell DG; Monks A
    Mol Pharmacol; 2006 Mar; 69(3):737-48. PubMed ID: 16332985
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technology evaluation: SAGE, Genzyme molecular oncology.
    Bartlett J
    Curr Opin Mol Ther; 2001 Feb; 3(1):85-96. PubMed ID: 11249736
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase 1 gene expression and sensitization of multidrug-resistant neuroblastoma cell lines to cytotoxic agents by depsipeptide.
    Keshelava N; Davicioni E; Wan Z; Ji L; Sposto R; Triche TJ; Reynolds CP
    J Natl Cancer Inst; 2007 Jul; 99(14):1107-19. PubMed ID: 17623797
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of an agent selectively targeting DPC4 (deleted in pancreatic cancer locus 4)-deficient pancreatic cancer cells.
    Wang H; Han H; Von Hoff DD
    Cancer Res; 2006 Oct; 66(19):9722-30. PubMed ID: 17018631
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation of PIK3Ca mutations with gene expression and drug sensitivity in NCI-60 cell lines.
    Whyte DB; Holbeck SL
    Biochem Biophys Res Commun; 2006 Feb; 340(2):469-75. PubMed ID: 16376301
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs.
    Staege MS; Banning-Eichenseer U; Weissflog G; Volkmer I; Burdach S; Richter G; Mauz-Körholz C; Föll J; Körholz D
    Exp Hematol; 2008 Jul; 36(7):886-96. PubMed ID: 18400362
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparing solid tumors with cell lines: implications for identifying drug resistance genes in cancer.
    Szakács G; Gottesman MM
    Mol Interv; 2004 Dec; 4(6):323-5. PubMed ID: 15616161
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of gene expression profiles in melanoma cells with acquired resistance against antineoplastic drugs.
    Györffy B; Serra V; Materna V; Schäfer R; Dietel M; Schadendorf D; Lage H
    Melanoma Res; 2006 Apr; 16(2):147-55. PubMed ID: 16567970
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression microarray analysis reveals genes associated with in vitro resistance to cisplatin in a cell line model.
    Watson MB; Lind MJ; Smith L; Drew PJ; Cawkwell L
    Acta Oncol; 2007; 46(5):651-8. PubMed ID: 17562441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Analysis of differential expression genes related to different metastasis potential of adenoid cystic carcinoma using restriction fragments differential display PCR].
    Lu YG; Zhou HY; Ding LC; Mei Y; Xiong RH; Deng SS; Yang HJ
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Oct; 23(5):505-10. PubMed ID: 17029196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Linking pathway gene expressions to the growth inhibition response from the National Cancer Institute's anticancer screen and drug mechanism of action.
    Huang R; Wallqvist A; Thanki N; Covell DG
    Pharmacogenomics J; 2005; 5(6):381-99. PubMed ID: 16103895
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genotoxic profiling of MCF-7 breast cancer cell line elucidates gene expression modifications underlying toxicity of the anticancer drug 2-(4-amino-3-methylphenyl)-5-fluorobenzothiazole.
    Monks A; Harris E; Hose C; Connelly J; Sausville EA
    Mol Pharmacol; 2003 Mar; 63(3):766-72. PubMed ID: 12606787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of microarray and sage techniques in gene expression analysis of human glioblastoma.
    Kavsan VM; Dmitrenko VV; Shostak KO; Bukreieva TV; Vitak NY; Simirenko OE; Malisheva TA; Shamayev MI; Rozumenko VD; Zozulya YA
    Tsitol Genet; 2007; 41(1):36-55. PubMed ID: 17427416
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Arpc1b gene is a candidate prediction marker for choroidal malignant melanomas sensitive to radiotherapy.
    Kumagai K; Nimura Y; Mizota A; Miyahara N; Aoki M; Furusawa Y; Takiguchi M; Yamamoto S; Seki N
    Invest Ophthalmol Vis Sci; 2006 Jun; 47(6):2300-4. PubMed ID: 16723437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Selection of genes related to multidrug resistance of pancreatic ductal adenocarcinoma by microarray analysis].
    Feng B; Zhao YP; Chen G; Zhang TP; Wu YD
    Zhonghua Wai Ke Za Zhi; 2007 Dec; 45(23):1629-33. PubMed ID: 18453221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Panel of human cancer cell lines provides valuable database for drug discovery and bioinformatics.
    Yamori T
    Cancer Chemother Pharmacol; 2003 Jul; 52 Suppl 1():S74-9. PubMed ID: 12819939
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of pathway or functionally related gene expression in the National Cancer Institute's anticancer screen.
    Huang R; Wallqvist A; Covell DG
    Genomics; 2006 Mar; 87(3):315-28. PubMed ID: 16386875
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered expression of proliferation-inducing and proliferation-inhibiting genes might contribute to acquired doxorubicin resistance in breast cancer cells.
    Saleh EM; El-Awady RA; Abdel Alim MA; Abdel Wahab AH
    Cell Biochem Biophys; 2009; 55(2):95-105. PubMed ID: 19593673
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.